Parathyroid hormone plus alendronate - A combination that does not add up

被引：44

作者：

Khosla, S ^{[1
]}

机构：

[1] Mayo Clin, Div Metab Endocrinol & Nutr, Endocrine Res Unit, Rochester, MN 55905 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2003年 / 349卷 / 13期

关键词：

D O I：

10.1056/NEJMe038143

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1277 / 1279

页数：3

共 11 条

[1] The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis [J].

Black, DM ;

Greenspan, SL ;

Ensrud, KE ;

Palermo, L ;

McGowan, JA ;

Lang, TF ;

Garnero, P ;

Bouxsein, ML ;

Bilezikian, JP ;

Rosen, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (13) :1207-1215

[2] Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys [J].

Burr, DB ;

Hirano, T ;

Turner, CH ;

Hotchkiss, C ;

Brommage, R ;

Hock, JM .

JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (01) :157-165

[3] Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis:: A paired biopsy study [J].

Dempster, DW ;

Cosman, F ;

Kurland, ES ;

Zhou, H ;

Nieves, J ;

Woelfert, L ;

Shane, E ;

Plavetic, K ;

Müller, R ;

Bilezikian, J ;

Lindsay, R .

JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (10) :1846-1853

[4] The effects of parathyroid hormone, alendronate, or both in men with osteoporosis [J].

Finkelstein, JS ;

Hayes, A ;

Hunzelman, JL ;

Wyland, JJ ;

Lee, H ;

Neer, RM .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (13) :1216-1226

[5] Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis - A randomized, double-blind, placebo-controlled trial [J].

Greenspan, SL ;

Emkey, RD ;

Bone, HG ;

Weiss, SR ;

Bell, NH ;

Downs, RW ;

McKeever, C ;

Miller, SS ;

Davidson, M ;

Bolognese, MA ;

Mulloy, AL ;

Heyden, N ;

Wu, M ;

Kaur, A ;

Lombardi, A .

ANNALS OF INTERNAL MEDICINE, 2002, 137 (11) :875-883

[6] Stemming bone loss by suppressing apoptosis [J].

Hock, JM .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (04) :371-373

[7] EFFECTS OF CONTINUOUS AND INTERMITTENT ADMINISTRATION AND INHIBITION OF RESORPTION ON THE ANABOLIC RESPONSE OF BONE TO PARATHYROID-HORMONE [J].

HOCK, JM ;

GERA, I .

JOURNAL OF BONE AND MINERAL RESEARCH, 1992, 7 (01) :65-72

[8] Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone [J].

Jilka, RL ;

Weinstein, RS ;

Bellido, T ;

Roberson, P ;

Parfitt, AM ;

Manolagas, SC .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (04) :439-446

[9] Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. [J].

Neer, RM ;

Arnaud, CD ;

Zanchetta, JR ;

Prince, R ;

Gaich, GA ;

Reginster, JY ;

Hodsman, AB ;

Eriksen, EF ;

Ish-Shalom, S ;

Genant, HK ;

Wang, OH ;

Mitlak, BH .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (19) :1434-1441

[10] Parathyroid hormone and periosteal bone expansion [J].

Parfitt, AM .

JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (10) :1741-1743

← 1 2 →